The main antigenic site (site A) of foot-and-mouth disease virus (FMDV, strain C-S8c1) may be adequately reproduced by a 15-peptide with the amino acid sequence H-YTASARGDLAHLTTT-NH 2 (A15), corresponding to the residues 136±150 of the viral protein VP1. The eect of amino acid substitutions within A15 on its antigenicity towards monoclonal antibodies (MAb) raised against antigenic site A, has been studied by means of BIAcore technology, based on surface plasmon resonance (SPR). Although these antigenicities have previously been determined from enzyme-linked immunosorbent assays (ELISA), the SPRbased technique is superior in that it allows a fast and straightforward screening of antigens while simultaneously providing kinetic data of the antigen±antibody interaction. With a view to screening fairly large libraries of individual peptides, we have inverted the typical SPR experiment by immobilizing the MAb on the sensor surface and using peptides as soluble analytes. We report the validation of this approach through the screening of 44 site A peptides, with results generally in good agreement with the relative antigenicities previously determined by competition ELISA. #
Introduction
The study of biospeci®c macromolecular interactions is central to an understanding of the molecular mechanisms involved in viral infection and may help in the rational design of synthetic vaccines. The antigen±anti-body reaction involves a series of molecular events that can be analyzed by dierent biophysical methods to provide qualitative or quantitative data on the binding reaction. Optical spectroscopies, particularly those based on¯uorescence, have been widely employed so far, but with the introduction of surface plasmon resonance (SPR) in the early '90s, optical evanescent wave biosensors have become increasingly popular for characterization of reversible biospeci®c reactions [1± 9] . SPR is an optical detection method that allows to monitor macromolecular interactions directly, in realtime and in a label-free mode, in contrast with indirect methods such as enzyme-linked immunosorbent assays (ELISA) or¯uorescence spectroscopies requiring suitable tags. In addition, the ability to provide a realtime analysis means that not only anity data but also kinetic data can be obtained. Another attractive feature is that high purity or large amounts of the biomolecules are not strictly required [1,7±10] . The technique relies on the covalent immobilization of one interactant (the ligand) onto a modi®ed dextran-coated gold surface, which forms one wall of a¯owcell [11, 12] . A solution of the other interactant (the ligate or analyte) is injected over this surface at continuous¯ow. Monochromatic p-polarized light is directed at the sensor surface and biomolecular binding events are detected as changes in the speci®c angle where SPR creates extinction of light [1, 7] . These changes re¯ect refractive index changes in the solution close to the 0264-410X/99/$ -see front matter # 1999 Elsevier Science Ltd. All rights reserved. PII: S 0 2 6 4 -4 1 0 X ( 9 9 ) 0 0 2 0 6 -6 www.elsevier.com/locate/vaccine surface, caused by the increase/decrease of mass due to analyte association/dissociation to the immobilized ligand. Therefore, measuring continuously the SPR angle provides a full record (a sensorgram) of the progress of the biospeci®c interaction.
Our research has been focused for some time on synthetic peptide vaccines against foot-and-mouth disease virus (FMDV), which causes the economically most important disease of cattle [13±18] . The high genetic variability of FMDV is responsible for the antigenic diversity among FMDV isolates and even within isolate subpopulations [13,16±19] . This fact is an important obstacle in the design of eective synthetic epitope-based vaccines. Ideally, such vaccines should include multiple epitopes to prevent the selection of resistant mutants in the ®eld, and the eects of amino acid substitutions in infection-involved epitopes should be well characterized at the molecular level. We have directed our attention to the various overlapping linear B-cell epitopes within antigenic site A [13±15,17], located on the G±H loop of FMDV. This site can be adequately reproduced by peptide A15 (H-YTASARGDLAHLTTT-NH 2 ), corresponding to residues 136±150 of viral protein VP1. We have previously described the eect of systematic single-residue changes on the antigenicity of site A [18] . Since we wished to characterize these antigenic responses not only at equilibrium but also in kinetic terms, SPR was the method of choice. However, given the large number of variant peptides, the only practical way to perform the screening consists of monoclonal antibody (MAb) immobilization and injection of peptide analytes. As direct detection of analytes smaller than 5000 Da is usually unfeasible with standard BIAcore protocols [20, 21] , we have carried out an extensive optimization of this approach using 44 of the 240 A15 single mutants as analytes and anti-site A MAb SD6 as ligand. The generally good agreement found between biosensor data and the anities known from ELISA [18] validates our analytical method.
Experimental procedures

Materials
MAb SD6 stock solution (1.6 mg/ml in PBS, pH 7.3) was obtained as described [14] by Dra. Nuria Verdaguer (CSIC, Barcelona). The antibody was desalted and buer-exchanged on Nap-5 Sephadex G-25 columns (Pharmacia) and the eluate quantitated by the Pierce BCA protein assay method (Pierce). The synthesis and puri®cation of A15 analogues has been previously described [18] . Consumables for the BIAcore 1000 instrument (CM5 certi®ed sensor chips, HBS buer, the amine coupling reagents N-hydroxysuccinimide (NHS) and N-ethyl-N '-dimethylaminopropyl-carbodiimide (EDC), ethanolamine) as well as the BIAevaluation 3.0.1 software were all from Biosensor AB (Uppsala, Sweden).
Biosensor experiments 2.2.1. M ab pre-concentration and immobilization
SD6 solutions (100 and 50 mg/ml, in either 10 mM acetate, pH 5.0 or 5 mM maleate, pH 6.0) were separately injected (30 ml) at 5 ml/min over a non-activated sensor surface in order to determine which gave the most ecient pre-concentration of Mab into the dextran matrix. Three SD6 surfaces were prepared using the standard amine coupling procedure as described by the manufacturer. Each carboxymethyl surface was activated with a 35 ml injection (at 5 ml/min) of a NHS/EDC mixture and SD6 was then coupled at three dierent densities by exposing each surface to 35 ml injections of SD6 in 10 mM acetate buer pH 5.0 at concentrations of 50, 5 and 3 mg/ml, respectively. Unreacted activated groups were blocked by a 30 ml injection of ethanolamine and remaining non-covalently bound molecules were washed o in a regeneration step with a 3-min pulse of 100 mM HCl. The ®nal densities of immobilized SD6 were 8000, 1700 and 800 RU, respectively (1000 RU corresponding to a 1 ng/mm 2 surface density).
Optimization of the experimental parameters
A few sets of experiments, using A15 as analyte, were run on the three SD6 surfaces at dierent peptide concentrations (ranging from 1 to 2440 nM) and¯ow rates (5 and 60 ml/min). A 2.44 mM solution of peptide in 100 mM acetic acid was used as stock, from which assay samples were prepared by 1000-fold and subsequent serial dilutions in HBS. All experiments were done in HBS running buer at 258C, using the`kinjection' mode in order to obtain accurate kinetic data by decreasing sample dispersion at the injection plugs. To generate the sensorgrams peptide injections during 7 min followed by 6 min of dissociation in running buffer were used, prior to the regeneration cycle (2-min pulse with 100 mM HCl).
Kinetic analysis of A15 analogues
Once suitable experimental conditions for kinetic screening of site A peptides had been established (see Section 4), a systematic analysis of 43 A15 analogues was performed, in order to compare biosensor kinetic data with anities previously determined by competition ELISA. This analysis was done on a medium density SD6 surface (1700 RU of immobilized MAb), at peptide concentrations ranging from ca. 2500 to 150 nM. Stock peptide solutions were quantitated by amino acid analysis. Sensorgrams were generated at a 60 ml/min¯ow rate and`kinjections' consisted on a 90 s association step, followed by a 240 s dissociation in running buer. A 90 s pulse of 100 mM HCl was applied to regenerate the surface at the end of each cycle. A pentadecapeptide, A15scr, containing the constituient amino acids of A15 in a random sequence (H-RAGTATTLADLHYST-NH 2 ) was injected under the same conditions as a control for instrument artifacts such as refractive index changes and non-speci®c binding.
Data analysis
Biosensor data were prepared, modelled and ®tted by means of the BIAevaluation 3.0.1. software. Calculations are carried out by numerical integration [22] and global curve ®tting is done by non-linear least-squares analysis [23] applied simultaneously to the entire data set [10, 24] . The quality of the ®tted data can be evaluated by comparison between the modeled and the experimental sensorgrams, as well as by statistical parameters such as the chi squared, given by Eq. (1), where r f is the ®tted value at a given point, r x is the experimental value at the same point, n is the number of data points and p is the number of degrees of freedom.
The reaction models and correspondent dierential rate equations tested are presented in Table 1 .
Results and discussion
Optimization of the experimental setup
In our ®rst approach, we tried to overcome the detection problems to be expected from the low molecular weight (MW) of our analytes by using a very dense SD6 surface (8 ng/mm 2 ) and high peptide concentrations at a low¯ow rate (5 ml/min). The sensorgrams generated under these conditions (Fig. 1a) could not be ®tted to the 1:1 bimolecular model (Table 1) as inferred from the high and non-random residuals obtained (Fig. 1b) and from the fact that the association rate constant was concentration-dependent (Fig.  1c) . Fitting the data to the heterogeneous ligand model (Table 1) , the residuals were lower and randomly distributed, but the values for k a1 and k a2 were still concentration-dependent (data not shown). Since previous X-ray diraction crystallographic studies have suggested that SD6 binds to FMDV C-S8c1 through a single Fab fragment [14, 18] , we expected a 1:1 SD6/ A15 interaction. Therefore, the inconsistency of the kinetic data was attributed to the high SD6 density employed, which generated signi®cant heterogeneity in ligand accessibility and orientation, as well as favoured diusion-controlled delivery of analyte to the most hindered SD6 molecules [25] . Analysis of a broad range of A15 concentrations at the same¯ow rate but over less dense (1.7 and 0.8 ng/mm 2 ) SD6 surfaces did not improve the results, the former surface producing equally inconsistent data and the latter being useless given the extremely low signal-to-noise ratios (data not shown). Therefore, and using again a medium-density SD6 surface (1.7 ng/mm 2 ) and high peptide concentrations (150 to 2440 nM), we decided to increase the buer ow rate up to 60 ml/min to obviate the diusion-controlled kinetics which seemed the most probable source for the persisting deviations from the expected Langmuirian behaviour. Indeed, consistent and apparently reliable data were now obtained, with a random distribution of residuals within an interval of ca. 20.5 RU, except for injection plugs (Fig. 2b) . Linearity of k s versus peptide concentration (Eq. (2)) over the 32-fold concentration range was observed, thus k a was concentration independent (Fig. 2c) .
Modeled and experimental curves were virtually superimposable (Fig. 2a) and a w 2 smaller than 1 was obtained. Data self-consistency was further con®rmed by the total agreement between the values for the equilibrium association constant, K A , as obtained from the k a /k d ratio or from the plot of R eq versus peptide concentration (Eq. (3), Fig. 2d ) for a 1:1 interaction. From this same plot, a value of R max close to that predicted from the immobilization response, R immob (Eq. (4)) was obtained, thus indicating that the MAb was fully active. Table 2 Kinetic data of the interaction between MAb SD6 and 44 site A peptides, corrected for bulk eects (see text). Qualitative relative antigenicities obtained in ELISA competition assays [18] are represented, with a black box corresponding to IC 50 >100, a dark grey box to IC 50 =30 to 100, a light grey box to IC 50 =5 to 30 and a white box to IC 50 < 5. no, no interaction; nr, non-reliable data
Systematic analysis of site A peptides
Having found suitable experimental conditions for the kinetic analysis of the A15/SD6 interaction, we applied a similar protocol to the systematic screening of 43 other A15 analogues. Reduction of`kinjection' times (90 s for association, 240 s for dissociation) lowered sample, buer and time consumption, with no loss in sensorgram quality or kinetic information. The consistency and accuracy of the ®tted kinetic data obtained for the whole set of site A peptides were in every aspect similar to those described for A15 under the same conditions. The stability of SD6 surfaces to the repeated acidic regeneration cycles allowed us to screen the entire set over the same surface, without any detectable loss in MAb activity, thus providing reliable comparison among the dierent peptides.
The scrambled 15-mer sequence A15Scr had no apparent speci®c binding, but gave rise to a high bulk response, as observed for the other peptides analysed. Therefore, the curves obtained for each site A peptide were corrected by subtraction of the corresponding A15Scr sensorgrams. A discrete overall improvement in data quality (lower w 2 values) accompanied this correction and a general increase in K A was obtained. This anity increase re¯ected simultaneously an increase in k a and a k d decrease (data not shown). These ®ndings are consistent with the higher probability of analyte non-speci®c retention within the dextran matrix when high concentrations are used [8, 27] . This binding was probably a`response averaging' of the biospeci®c union with the non-speci®c analyte imprisonment. The corrected biosensor data for the 44 site A peptides analysed are shown in Table 2 , in which relative antigenicities derived from ELISA [18] are also represented. The general agreement observed between both techniques validates our analytical method for the antigenicity screening of low MW peptides using biosensor technology.
Concluding remarks
This investigation has served three major purposes: Although evanescent wave biosensors are successful [1±9] in that they provide simple and fast (`yes' or no') answers about the binding of analytes to a ligand, the quantitative data obtained from them are subject to several potential artifacts [7,8,25±28] . The most common sources for such artifacts are heterogeneity in ligand accessibility and orientation, as well as masstransport limitations. Methods for diagnosis and evaluation of these artifacts, such as global analysis of data sets generated in dierent surface capacities or self-consistency tests, are extensively discussed in the literature [24±32] . Nevertheless, these control tests, though helpful to ensure internally consistent data, provide no critical information about the validity of the kinetic parameters as absolute values. We minimized the undesired artifacts by adapting our experimental setup to high buer¯ow rate and the minimum surface capacity possible and thus obtained self-consistent kinetic and equilibrium data, further con®rmed by previous ELISA experiments [18] .
However, caution is still advisable in the evaluation of such kinetic data. Firstly, one cannot totally compare the events taking place in a biosensor experiment with those occurring in physiologic media. It must not be forgotten that although no labels are required in biosensor analysis, the ligand is still somehoẁ labelled' by its attachment to a sensor chip. Secondly, while ELISA provides a valuable check of the reliability of biosensor data, one cannot write o the possibility that mass-transport aects actual k a and k d values by a similar factor, thus providing thermodynamic constants apparently consistent with equilibrium experiments. In fact, a preliminary analysis of the A15/SD6 interaction using IAsys biosensor (a resonant mirror evanescent wave biosensor where a stirred cuvette, instead of a¯owcell, is claimed to overcome mass-transport limitations) showed virtually the same anity constant but slightly higher kinetic rate constants [33] .
Further experiments in progress include using other anti-site A MAbs as ligands and a high MW analyte (a 1:1 conjugate of A15 with a carrier protein) for real-time competitive analysis [20] . These experiments will hopefully provide further information on the validity of our methodology.
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